Clinical Research Directory
Browse clinical research sites, groups, and studies.
Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency Anemia
Sponsor: Western Galilee Hospital-Nahariya
Summary
The purpose of this study is to compare maternal outcomes such as increased hemoglobin need for blood transfusion and hemoglobin level before and post partum in women with hemoglobin \<9 gr/dl , treated with venofer and women treated with ferinject.
Official title: Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency Anemia (Hb<9)
Key Details
Gender
FEMALE
Age Range
18 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2023-11-02
Completion Date
2027-12
Last Updated
2026-09-11
Healthy Volunteers
No
Conditions
Interventions
Venofer 200 MG Per 10 ML Injection
treat anemia with venofer up to 5 doses
Ferinject
ferinject 500 mg, once a week for 2 weeks
Locations (1)
Galilee Medical Center
Nahariya, Israel